$132.0 Million
Akebia Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$120.0 Million
Aeglea BioTherapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$85.3 Million
Sutro Biopharma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$115.1 Million
Crinetics Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$97.8 Million
SeaSpine Holdings Corporation
Confidentially Marketed Follow-On Offering
Active Bookrunner
$86.2 Million
Neoleukin Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$110.5 Million
Revance Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$53.6 Million
OptiNose AS
Confidentially Marketed Follow-On Offering
Active Bookrunner
$115.0 Million
Arvinas
Confidentially Marketed Follow-On Offering
Active Bookrunner
$143.8 Million
Ardelyx Inc
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.